Cyclerion Therapeutics announces $380 million private placement

• Cyclerion announced a $380 million private placement tied to the closing of its merger with Korsana Biosciences.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclerion Therapeutics Inc. published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.